143 related articles for article (PubMed ID: 11371681)
1. Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport.
Jones K; Hoggard PG; Sales SD; Khoo S; Davey R; Back DJ
AIDS; 2001 Apr; 15(6):675-81. PubMed ID: 11371681
[TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
[TBL] [Abstract][Full Text] [Related]
3. Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro.
Jones K; Hoggard PG; Khoo S; Maher B; Back DJ
Br J Clin Pharmacol; 2001 Jan; 51(1):99-102. PubMed ID: 11167671
[TBL] [Abstract][Full Text] [Related]
4. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
[TBL] [Abstract][Full Text] [Related]
5. Intracellular accumulation of human immunodeficiency virus protease inhibitors.
Khoo SH; Hoggard PG; Williams I; Meaden ER; Newton P; Wilkins EG; Smith A; Tjia JF; Lloyd J; Jones K; Beeching N; Carey P; Peters B; Back DJ
Antimicrob Agents Chemother; 2002 Oct; 46(10):3228-35. PubMed ID: 12234849
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters.
Srinivas RV; Middlemas D; Flynn P; Fridland A
Antimicrob Agents Chemother; 1998 Dec; 42(12):3157-62. PubMed ID: 9835508
[TBL] [Abstract][Full Text] [Related]
7. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
Su Y; Zhang X; Sinko PJ
Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
[TBL] [Abstract][Full Text] [Related]
8. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
9. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
10. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
Moore DM; Hogg RS; Yip B; Wood E; Harris M; Montaner JS
HIV Med; 2006 Jul; 7(5):311-6. PubMed ID: 16945076
[TBL] [Abstract][Full Text] [Related]
11. Hepatic and intestinal contributions to pharmacokinetic interaction of indinavir with amprenavir, nelfinavir and saquinavir in rats.
Gao W; Kishida T; Kageyama M; Kimura K; Yoshikawa Y; Shibata N; Takada K
Antivir Chem Chemother; 2002 Jan; 13(1):17-26. PubMed ID: 12180646
[TBL] [Abstract][Full Text] [Related]
12. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.
Zhang L; Gorset W; Washington CB; Blaschke TF; Kroetz DL; Giacomini KM
Drug Metab Dispos; 2000 Mar; 28(3):329-34. PubMed ID: 10681378
[TBL] [Abstract][Full Text] [Related]
13. The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects.
Boffito M; Hoggard PG; Reynolds HE; Bonora S; Meaden ER; Sinicco A; Di Perri G; Back DJ
Br J Clin Pharmacol; 2002 Sep; 54(3):262-8. PubMed ID: 12236846
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals.
Meaden ER; Hoggard PG; Newton P; Tjia JF; Aldam D; Cornforth D; Lloyd J; Williams I; Back DJ; Khoo SH
J Antimicrob Chemother; 2002 Oct; 50(4):583-8. PubMed ID: 12356805
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries.
Chai H; Yang H; Yan S; Li M; Lin PH; Lumsden AB; Yao Q; Chen C
J Acquir Immune Defic Syndr; 2005 Sep; 40(1):12-9. PubMed ID: 16123675
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS.
Chi J; Jayewardene AL; Stone JA; Motoya T; Aweeka FT
J Pharm Biomed Anal; 2002 Oct; 30(3):675-84. PubMed ID: 12367693
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell line.
Maffeo A; Bellomi F; Solimeo I; Bambacioni F; Scagnolari C; De Pisa F; Dupuis ML; Cianfriglia M; Antonelli G; Turriziani O
New Microbiol; 2004 Apr; 27(2 Suppl 1):119-26. PubMed ID: 15646074
[TBL] [Abstract][Full Text] [Related]
18. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Lucia MB; Rutella S; Leone G; Vella S; Cauda R
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
[TBL] [Abstract][Full Text] [Related]
19. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
Berginc K; Trdan T; Trontelj J; Kristl A
Biopharm Drug Dispos; 2010 Nov; 31(8-9):495-505. PubMed ID: 21104925
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of HIV-1 protease inhibitors on P-glycoprotein function in multidrug-resistant variants of the human CD4+ T lymphoblastoid CEM cell line.
Dupuis ML; Tombesi M; Sabatini M; Cianfriglia M
Chemotherapy; 2003 May; 49(1-2):8-16. PubMed ID: 12714803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]